EW - Edwards Lifesciences: A Med-Tech Stock Staying Strong For A Reason

Introduction

Edwards Lifesciences (EW) describes itself this way:

... we continue to lead the field of tissue replacement heart valves and repair products and advanced hemodynamic monitoring, which have helped treat and manage more than 2 million patients worldwide.

EW was spun off by Baxter (BAX) 19 years ago with a lot of debt and uncertain prospects. As this chart compares EW with two major competitors and the S&P 500 (SPY), it has been discovered:

Data by YCharts

EW trades with about 2X the prices:sales ratio of Boston Scientific

Read more ...